Suven Life Sciences Ltd (SUVEN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 588414,
    "name": "Suven Life Scie.",
    "stock_name": "Suven Life Scie.",
    "full_name": "Suven Life Sciences Ltd",
    "name_url": "stocks-analysis/suven-life-scie",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "149.00",
    "chg": 11.35,
    "chgp": "8.25%",
    "dir": 1,
    "prev_price": "137.65",
    "mcapval": "3,297.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530239,
    "symbol": "SUVEN",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE495B01038",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "5.19 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/suven-life-scie-588414-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Suven Life Scie. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-suven-life-scie-technically-bullish-or-bearish-3745392",
        "imagepath": "",
        "date": "2025-12-04 08:29:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Recent Price Movements</strong></p>\n<p>As of the latest trading session, Suven Life Sciences closed at ₹172.70, slightly down from the previous close of ₹173.30. The stock’s intraday range spanned from ₹172.40 to ₹176.90, reflecting modest volatility. When compared to its 52-week high of ₹303.00 and a low of ₹102.70, the current price sits closer to the lower half of this range, indicating a significant retracement from its peak levels.</p>\n<p><strong>Technical Indicators: Mixed Signals</strong></p>\n<p>The technical landscape for Suven Life Sciences presents a nuanced picture. The Moving Average Convergence Divergence (MACD) indicator, a popular momentum tool, signals bearishness on the weekly chart and mildly bearish conditions on the monthly chart. This suggests that the medium..."
      },
      {
        "title": "Suven Life Sciences Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-faces-technical-momentum-shift-amid-mixed-indicator-signals-3745441",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SuvenLifeScienc_technicaldot_3745441.png",
        "date": "2025-12-04 08:07:51",
        "description": "Suven Life Sciences has experienced a notable shift in its technical momentum, reflecting a complex interplay of market indicators that suggest a transition from a mildly bullish to a mildly bearish trend. This development comes amid mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, underscoring the nuanced market assessment of the healthcare services stock."
      },
      {
        "title": "Suven Life Sciences Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-forms-death-cross-signalling-potential-bearish-trend-3744638",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SuvenLifeScienc_dealthcross_3744638.png",
        "date": "2025-12-03 18:01:42",
        "description": "Suven Life Sciences has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and may indicate weakening momentum in the stock’s price action over the longer term."
      },
      {
        "title": "Suven Life Scie. Sees Revision in Market Assessment Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suven-life-sciences-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3735120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SuvenLifeScie_mojoScore_3735120.png",
        "date": "2025-11-28 10:05:47",
        "description": "Suven Life Scie., a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting ongoing operational and financial challenges. This shift in assessment highlights the company's current standing amid a backdrop of declining sales, persistent losses, and cautious investor sentiment."
      },
      {
        "title": "Why is Suven Life Scie. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-suven-life-scie-fallingrising-3726935",
        "imagepath": "",
        "date": "2025-11-25 01:17:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Suven Life Sciences has experienced a sustained downward trend over the past week, with the stock falling 6.69% compared to a marginal 0.06% decline in the Sensex benchmark. Over the last month, the stock’s decline has been even more pronounced at 15.43%, while the Sensex gained 0.82%. Despite these short-term setbacks, the stock has delivered strong returns over longer periods, with a year-to-date gain of 31.17% and a one-year return of 43.80%, significantly outperforming the Sensex’s 8.65% and 7.31% respectively. The three- and five-year returns are also impressive, at 156.65% and 253.40%, well above the benchmark’s 36.34% and 90.69%.</p>\n<p>However, the recent price action is concerning. The stock has declined for three consecut..."
      },
      {
        "title": "Why is Suven Life Scie. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-suven-life-scie-fallingrising-3713241",
        "imagepath": "",
        "date": "2025-11-18 23:02:28",
        "description": "As of 18-Nov, Suven Life Sciences Ltd is experiencing a decline in its stock price, currently at Rs 178.50, which represents a decrease of Rs 2.35 or 1.3%. The stock has underperformed its sector by 0.68% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 4.21%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a strong year-to-date return of 38.75% and a 48.56% increase over the past year, the company has reported negative results for the last five consecutive quarters, with a significant operating loss and declining net sales, which contribute to its weak long-term fundamental strength.\n\nIn the broader market context, the stock's short-term performance has been notably poor compared to the Sensex, which has gained 0.96% over the past week while Suven Life Scien..."
      },
      {
        "title": "How has been the historical performance of Suven Life Scie.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-suven-life-scie-3694738",
        "imagepath": "",
        "date": "2025-11-12 23:53:18",
        "description": "Answer:\nThe historical performance of Suven Life Sciences has shown a significant decline in key financial metrics over the years, particularly in net sales and profitability.\n\nBreakdown:\nSuven Life Sciences reported net sales of 6.66 crore in March 2025, a sharp decrease from 11.69 crore in March 2024 and 13.54 crore in March 2023, continuing a downward trend from 285.67 crore in March 2019. The total operating income mirrored this decline, dropping to 6.66 crore in March 2025 from 11.69 crore in the previous year. The company's total expenditure, excluding depreciation, rose to 172.43 crore in March 2025, up from 139.70 crore in March 2024, leading to an operating profit (PBDIT) of -165.77 crore in March 2025, worsening from -128.01 crore in March 2024. Consequently, the profit before tax also deteriorated to -160.75 crore in March 2025, compared to -106.08 crore in March 2024. The net profit for March 20..."
      },
      {
        "title": "Are Suven Life Scie. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-suven-life-scie-latest-results-good-or-bad-3690509",
        "imagepath": "",
        "date": "2025-11-11 19:37:18",
        "description": "Suven Life Sciences' latest financial results for Q2 FY26 reveal significant operational challenges. The company reported net sales of ₹1.87 crores, reflecting a year-on-year growth of 85.15%. However, this growth is from a very low base and translates to only a nominal increase in absolute terms, indicating persistent difficulties in generating substantial revenue. The sequential growth of 27.21% from the previous quarter offers limited reassurance given the overall weak financial performance.\n\nThe net loss for the quarter was ₹51.52 crores, which represents a notable increase in losses compared to the previous year. The operating margin, excluding other income, was reported at -2713.37%, highlighting a severe disconnect between the company's revenue generation and its operational expenses. Employee costs alone accounted for ₹5.98 crores, significantly exceeding the company's revenue, which raises concerns..."
      },
      {
        "title": "Suven Life Sciences Q2 FY26: Mounting Losses Signal Deepening Crisis as Revenue Struggles Continue",
        "link": "https://www.marketsmojo.com/news/result-analysis/suven-life-sciences-q2-fy26-mounting-losses-signal-deepening-crisis-as-revenue-struggles-continue-3689959",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SuvenLifeScienc_quaterlyResult_3689959.png",
        "date": "2025-11-11 15:20:49",
        "description": "Suven Life Sciences Ltd., a small-cap healthcare services company with a market capitalisation of ₹4,193 crores, reported a net loss of ₹51.52 crores in Q2 FY26, marking an 83.74% year-on-year deterioration from the ₹28.04 crore loss in Q2 FY25. On a sequential basis, the loss expanded by 17.25% from ₹43.94 crores in Q1 FY26. The company's stock price closed at ₹182.50 on November 11, 2025, down 2.48% on the day, reflecting investor concerns about the persistent operational challenges facing this Hyderabad-based firm."
      }
    ],
    "total": 5221,
    "sid": "588414",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/suven-life-sciences-588414"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Jan-2026",
      "details": "Newspaper advt. - Unaudited financial results for the quarter and nine months ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of The Meeting Of Board Of Directors Of Suven Life Sciences Limited Held On Thursday January 29 2026",
      "datetime": "29-Jan-2026",
      "details": "Outcome of the Meeting of Board of Directors",
      "source": "BSE"
    },
    {
      "caption": "Appointment of Company Secretary and Compliance Officer",
      "datetime": "29-Jan-2026",
      "details": "Appointment of Ms. Sangeetha Laxmi Kandari (ICSI M. No. A40736) as Company Secretary & Compliance Officer (KMP) of the Company",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has declared <strong>150%</strong> dividend, ex-date: 14 Feb 19",
          "dt": "2019-02-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has announced <strong>1:2</strong> stock split, ex-date: 23 Mar 07",
          "dt": "2007-03-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Mar 07",
          "dt": "2007-03-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has announced <strong>1:2</strong> rights issue, ex-date: 17 Oct 22",
          "dt": "2022-10-17",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Is Suven Life Scie. technically bullish or bearish?

2025-12-04 08:29:26

Overview of Recent Price Movements As of the latest trading session, Suven Life Sciences closed at ₹172.70, slightly down from the previous close of ₹173.30. The stock’s intraday range spanned from ₹172.40 to ₹176.90, reflecting modest volatility. When compared to its 52-week high of ₹303.00 and a low of ₹102.70, the current price sits closer to the lower half of this range, indicating a significant retracement from its peak levels. Technical Indicators: Mixed Signals The technical landscape for Suven Life Sciences presents a nuanced picture. The Moving Average Convergence Divergence (MACD) indicator, a popular momentum tool, signals bearishness on the weekly chart and mildly bearish conditions on the monthly chart. This suggests that the medium...

Suven Life Sciences Technical Momentum Shifts Amid Mixed Market Signals

2025-12-04 08:07:51

Suven Life Sciences has experienced a notable shift in its technical momentum, reflecting a complex interplay of market indicators that suggest a transition from a mildly bullish to a mildly bearish trend. This development comes amid mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, underscoring the nuanced market assessment of the healthcare services stock.

Suven Life Sciences Forms Death Cross Signalling Potential Bearish Trend

2025-12-03 18:01:42

Suven Life Sciences has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and may indicate weakening momentum in the stock’s price action over the longer term.

Suven Life Scie. Sees Revision in Market Assessment Amidst Challenging Financials

2025-11-28 10:05:47

Suven Life Scie., a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting ongoing operational and financial challenges. This shift in assessment highlights the company's current standing amid a backdrop of declining sales, persistent losses, and cautious investor sentiment.

Why is Suven Life Scie. falling/rising?

2025-11-25 01:17:07

Recent Price Movement and Market Performance Suven Life Sciences has experienced a sustained downward trend over the past week, with the stock falling 6.69% compared to a marginal 0.06% decline in the Sensex benchmark. Over the last month, the stock’s decline has been even more pronounced at 15.43%, while the Sensex gained 0.82%. Despite these short-term setbacks, the stock has delivered strong returns over longer periods, with a year-to-date gain of 31.17% and a one-year return of 43.80%, significantly outperforming the Sensex’s 8.65% and 7.31% respectively. The three- and five-year returns are also impressive, at 156.65% and 253.40%, well above the benchmark’s 36.34% and 90.69%. However, the recent price action is concerning. The stock has declined for three consecut...

Why is Suven Life Scie. falling/rising?

2025-11-18 23:02:28

As of 18-Nov, Suven Life Sciences Ltd is experiencing a decline in its stock price, currently at Rs 178.50, which represents a decrease of Rs 2.35 or 1.3%. The stock has underperformed its sector by 0.68% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 4.21%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a strong year-to-date return of 38.75% and a 48.56% increase over the past year, the company has reported negative results for the last five consecutive quarters, with a significant operating loss and declining net sales, which contribute to its weak long-term fundamental strength. In the broader market context, the stock's short-term performance has been notably poor compared to the Sensex, which has gained 0.96% over the past week while Suven Life Scien...

How has been the historical performance of Suven Life Scie.?

2025-11-12 23:53:18

Answer: The historical performance of Suven Life Sciences has shown a significant decline in key financial metrics over the years, particularly in net sales and profitability. Breakdown: Suven Life Sciences reported net sales of 6.66 crore in March 2025, a sharp decrease from 11.69 crore in March 2024 and 13.54 crore in March 2023, continuing a downward trend from 285.67 crore in March 2019. The total operating income mirrored this decline, dropping to 6.66 crore in March 2025 from 11.69 crore in the previous year. The company's total expenditure, excluding depreciation, rose to 172.43 crore in March 2025, up from 139.70 crore in March 2024, leading to an operating profit (PBDIT) of -165.77 crore in March 2025, worsening from -128.01 crore in March 2024. Consequently, the profit before tax also deteriorated to -160.75 crore in March 2025, compared to -106.08 crore in March 2024. The net profit for March 20...

Are Suven Life Scie. latest results good or bad?

2025-11-11 19:37:18

Suven Life Sciences' latest financial results for Q2 FY26 reveal significant operational challenges. The company reported net sales of ₹1.87 crores, reflecting a year-on-year growth of 85.15%. However, this growth is from a very low base and translates to only a nominal increase in absolute terms, indicating persistent difficulties in generating substantial revenue. The sequential growth of 27.21% from the previous quarter offers limited reassurance given the overall weak financial performance. The net loss for the quarter was ₹51.52 crores, which represents a notable increase in losses compared to the previous year. The operating margin, excluding other income, was reported at -2713.37%, highlighting a severe disconnect between the company's revenue generation and its operational expenses. Employee costs alone accounted for ₹5.98 crores, significantly exceeding the company's revenue, which raises concerns...

Suven Life Sciences Q2 FY26: Mounting Losses Signal Deepening Crisis as Revenue Struggles Continue

2025-11-11 15:20:49

Suven Life Sciences Ltd., a small-cap healthcare services company with a market capitalisation of ₹4,193 crores, reported a net loss of ₹51.52 crores in Q2 FY26, marking an 83.74% year-on-year deterioration from the ₹28.04 crore loss in Q2 FY25. On a sequential basis, the loss expanded by 17.25% from ₹43.94 crores in Q1 FY26. The company's stock price closed at ₹182.50 on November 11, 2025, down 2.48% on the day, reflecting investor concerns about the persistent operational challenges facing this Hyderabad-based firm.

View All News